DeepTek CXR Analyzer vs Stethee Pro 1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

DeepTek CXR Analyzer

by DeepTek

Stethee Pro 1

by M3DICINE

AI Verdict

These tools are adjacent rather than direct competitors, as they address different diagnostic modalities within similar specialties. DeepTek CXR Analyzer is designed for AI-powered interpretation of chest X-ray images, assisting radiologists with pathology detection. In contrast, Stethee Pro 1 is an AI-enabled digital stethoscope for real-time cardiac and respiratory sound analysis and vital sign capture, primarily for clinical examination and telemedicine.

Choose DeepTek CXR Analyzer if…

Choose DeepTek CXR Analyzer if your radiology department or imaging center processes a high volume of chest X-rays and aims to significantly enhance workflow efficiency and diagnostic accuracy. This AI-powered CADe solution is ideal for assisting radiologists by automatically identifying and highlighting suspicious regions across various pathologies, thereby reducing workload and improving throughput for initial screenings.

View DeepTek CXR Analyzer →

Choose Stethee Pro 1 if…

Choose Stethee Pro 1 if you require an advanced, portable, and AI-enabled digital stethoscope for real-time cardiac and respiratory assessment, particularly in telemedicine, remote monitoring, or emergency settings. This system is best suited for clinicians who need sophisticated sound amplification, immediate vital sign analysis, and secure data sharing capabilities for enhanced remote diagnostics and patient management.

View Stethee Pro 1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	DeepTek CXR Analyzer	Stethee Pro 1
Pricing	Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription.	$499 usd
Deployment	On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment.	Cloud, Mobile
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepTek CXR Analyzer

DeepTek CXR Analyzer integrates seamlessly into existing PACS workflows, which is crucial for minimizing disruption and maximizing adoption in a radiology department. Its output is in DICOM format, making it easily interpretable within a radiologist's familiar environment. Stethee Pro 1, while modern, introduces a new physical device, mobile app, and web portal, potentially requiring more user adaptation.

Clinical Value

DeepTek CXR Analyzer

Both tools are FDA-cleared and offer significant clinical value. DeepTek CXR Analyzer directly enhances the diagnostic process for a high-volume imaging modality by detecting 28 pathologies and claiming a 30-50% reduction in workload and 2x-3x productivity boost for radiologists. Stethee Pro 1 augments physical examination with real-time vital sign analysis, but DeepTek's impact on a critical, high-throughput diagnostic workflow appears to offer a broader efficiency gain.

Pricing & Value

Stethee Pro 1

Stethee Pro 1 offers transparent pricing for its device and clearly outlines a subscription model for its web portal, allowing potential buyers to understand the costs upfront. DeepTek CXR Analyzer's 'contact sales' and 'pay-per-use' model lacks this transparency, making it difficult to assess its value without direct engagement with the company.

Enterprise Readiness

DeepTek CXR Analyzer

DeepTek CXR Analyzer offers both cloud and on-premise deployment options, providing greater flexibility for large healthcare systems with diverse IT infrastructure and data governance requirements. Its seamless DICOM-based PACS integration also demonstrates strong readiness for integration into existing enterprise radiology workflows. Stethee Pro 1 is primarily cloud-based, which might be less adaptable for some enterprise environments.

Innovation

Stethee Pro 1

While both are innovative, Stethee Pro 1 stands out as 'The World's First AI-Enabled Wireless Stethoscope System', integrating AI into a traditional diagnostic tool for real-time analysis, advanced sound processing, and unique environmental data tagging. This represents a more foundational reimagining of a common clinical practice. DeepTek CXR Analyzer's innovation lies in its sophisticated AI for image analysis and workflow optimization, which is also significant but builds upon existing imaging workflows.

Support & Docs

Stethee Pro 1

M3DICINE's website for Stethee Pro 1 features a dedicated 'Support' section with categorized articles, a user manual, and specific how-to guides, indicating a structured and accessible knowledge base. DeepTek provides contact information and mentions a 'Resources Hub' with guides, but M3DICINE's support offering appears more detailed and readily available for self-service.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	DeepTek CXR Analyzer	Stethee Pro 1
Tool Name	DeepTek CXR Analyzer	Stethee Pro 1
Company	DeepTek Medical Imaging Pvt	M3DICINE Pty Ltd.
Description	FDA-cleared AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, significantly improving workflow efficiency and diagnostic accuracy.	FDA-cleared, AI-enabled wireless digital stethoscope system by M3DICINE, providing real-time cardiac and respiratory vital sign analysis, advanced amplification, and secure data sharing for enhanced diagnostics and telemedicine.
Primary Function	AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays	AI-enabled wireless digital stethoscope system for cardiac and respiratory vital sign analysis
Key Detections/Measurements	28 findings covering lung, pleural, cardiac pathologies, and hardware	Cardiac and respiratory vital signs (systole, diastole, heart cycle durations, respiration rate)

Videos

Demos, reviews, and walkthroughs featuring DeepTek CXR Analyzer and Stethee Pro 1.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into a physician's existing clinical workflow and what is the depth of their EHR integration?

DeepTek CXR Analyzer seamlessly integrates into existing radiology workflows via DICOM-based PACS, generating secondary capture DICOMs with AI output for direct interpretation, without altering current workflows. Stethee Pro 1 operates through a mobile app and a Central Web Portal, enabling secure data capture and sharing, with the ability to import data into electronic medical records and generate patient vital sign reports directly into the EHR.

What specific clinical performance metrics or accuracy data are available to help physicians understand the diagnostic reliability of each tool for their respective applications?

DeepTek CXR Analyzer is a CADe solution for chest X-rays, demonstrating an aggregate AUROC of 91.2% and sensitivity of 88.4% in detecting suspicious ROIs across lung, pleural, and cardiac regions, and improving radiologist performance when aided. Stethee Pro 1's AI algorithms are clinically validated to accurately measure systole, diastole, heart cycle durations, and respiration rate in 20 seconds, with its respiration rate detection algorithm showing 99.9% correlation with capnography.

Beyond the listed specialties, what are the key clinical scenarios or patient populations where each tool demonstrates its most significant utility?

DeepTek CXR Analyzer is highly valuable in high-volume radiology departments, emergency settings, and public health programs for rapid and accurate screening of chest X-rays, including for tuberculosis, and can interpret pediatric chest X-rays for children aged four and above. Stethee Pro 1 excels in telemedicine, remote monitoring, and point-of-care diagnostics in cardiology, pulmonology, and emergency medicine, offering detailed auscultation and vital sign capture for screening and monitoring acute and chronic conditions like heart failure, asthma, and COPD.

What is the expected learning curve for physicians to effectively utilize each tool, and how quickly can a practice expect to see a return on investment in terms of efficiency or improved patient care?

DeepTek CXR Analyzer integrates into existing PACS, meaning the learning curve primarily involves interpreting AI-highlighted regions within a familiar workflow, and it aims to reduce radiologist workload by 30-50% and boost productivity by 2x-3x. Stethee Pro 1 requires physicians to learn its digital interface and interpret real-time visualizations and analytics via its mobile app and web portal, offering immediate time-to-value through 20-second vital sign capture and enhanced diagnostic capabilities.

What considerations should be made for deploying each tool across multiple clinical sites, and what level of ongoing technical and clinical support is provided?

DeepTek CXR Analyzer's cloud or on-premise deployment options and DICOM integration offer flexibility for multi-site rollouts, with the company having deployed its solution at over 800 sites worldwide. Stethee Pro 1, with its wireless device, mobile app, and cloud portal, is designed for distributed use, facilitating multi-site deployment and remote data access and sharing for healthcare professionals.

Can the vendor provide customer references or case studies demonstrating real-world clinical outcomes and user satisfaction with the tool?

DeepTek CXR Analyzer has been adopted by over 500 hospitals and imaging centers, with a platform deployed as the National Radiology AI platform in Singapore, and claims 85% user satisfaction from clinicians. Stethee Pro 1 is described as a disruptive technology with the potential to revolutionize clinical practice, and M3DICINE is working with academic partners on global initiatives, suggesting real-world application and potential for case studies.